SC 13G/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)*

 

 

Chiasma, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

16706W 10 2

(CUSIP Number)

December 31, 2019

(Date of Event Which Requires Filing of This Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

Page 1 of 15


CUSIP No. 16706W 10 2

 

  1.    

  Name of Reporting Persons

 

   MPM BioVentures IV-QP, L.P.

  2.    

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☐        (b)  ☒

 

  3.    

  SEC USE ONLY

 

  4.    

  Citizenship or Place of Organization

 

  Delaware

Number of

Shares

  Beneficially  

Owned by

Each

Reporting

Person

With:

    5.     

  Sole Voting Power

 

  5,216,482*

  6.     

  Shared Voting Power

 

  0

  7.     

  Sole Dispositive Power

 

  5,216,482*

  8.     

  Shared Dispositive Power

 

  0

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  5,216,482*

10.    

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

  ☐

11.    

  Percent of Class Represented by Amount in Row (9)

 

  12.1%

12.    

  Type of Reporting Person (See Instructions)

 

  PN

 

*

Includes 1,196,908 shares of Common Stock issuable pursuant to warrants, which are exercisable within 60 days of the date of this filing.

 

Page 2 of 15


CUSIP No. 16706W 10 2

 

  1.    

  Name of Reporting Persons

 

  MPM BioVentures IV GmbH & Co. Beteiligungs KG

  2.    

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☐        (b)  ☒

 

  3.    

  SEC USE ONLY

 

  4.    

  Citizenship or Place of Organization

 

  Germany

Number of

Shares

  Beneficially  

Owned by

Each

Reporting

Person

With:

    5.     

  Sole Voting Power

 

  200,973*

  6.     

  Shared Voting Power

 

  0

  7.     

  Sole Dispositive Power

 

  200,973*

  8.     

  Shared Dispositive Power

 

  0

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  200,973*

10.    

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

  ☐

11.    

  Percent of Class Represented by Amount in Row (9)

 

  0.5%

12.    

  Type of Reporting Person (See Instructions)

 

  PN

 

*

Includes 46,112 shares of Common Stock issuable pursuant to warrants, which are exercisable within 60 days of the date of this filing.

 

Page 3 of 15


CUSIP No. 16706W 10 2

 

  1.    

  Name of Reporting Persons

 

  MPM Asset Management Investors BV4 LLC

  2.    

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☐        (b)  ☒

 

  3.    

  SEC USE ONLY

 

  4.    

  Citizenship or Place of Organization

 

  Delaware

Number of

Shares

  Beneficially  

Owned by

Each

Reporting

Person

With:

    5.     

  Sole Voting Power

 

  148,332*

  6.     

  Shared Voting Power

 

  0

  7.     

  Sole Dispositive Power

 

  148,332*

  8.     

  Shared Dispositive Power

 

  0

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  148,332*

10.    

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

  ☐

11.    

  Percent of Class Represented by Amount in Row (9)

 

  0.4%

12.    

  Type of Reporting Person (See Instructions)

 

  OO

 

*

Includes 34,033 shares of Common Stock issuable pursuant to warrants, which are exercisable within 60 days of the date of this filing.

 

Page 4 of 15


CUSIP No. 16706W 10 2

 

  1.    

  Name of Reporting Persons

 

  MPM Bio IV NVS Strategic Fund, L.P.

  2.    

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☐        (b)  ☒

 

  3.    

  SEC USE ONLY

 

  4.    

  Citizenship or Place of Organization

 

  Bermuda

Number of

Shares

  Beneficially  

Owned by

Each

Reporting

Person

With:

    5.     

  Sole Voting Power

 

  1,552,960*

  6.     

  Shared Voting Power

 

  0

  7.     

  Sole Dispositive Power

 

  1,552,960*

  8.     

  Shared Dispositive Power

 

  0

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  1,552,960*

10.    

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

  ☐

11.    

  Percent of Class Represented by Amount in Row (9)

 

  3.7%

12.    

  Type of Reporting Person (See Instructions)

 

  PN

 

*

Includes 105,398 shares of Common Stock issuable pursuant to warrants, which are exercisable within 60 days of the date of this filing.

 

Page 5 of 15


CUSIP No. 16706W 10 2

 

  1.    

  Name of Reporting Persons

 

  MPM BioVentures IV GP LLC

  2.    

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☐        (b)  ☒

 

  3.    

  SEC USE ONLY

 

  4.    

  Citizenship or Place of Organization

 

  Delaware

Number of

Shares

  Beneficially  

Owned by

Each

Reporting

Person

With:

    5.     

  Sole Voting Power

 

  0

  6.     

  Shared Voting Power

 

  6,970,415*

  7.     

  Sole Dispositive Power

 

  0

  8.     

  Shared Dispositive Power

 

  6,970,415*

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  6,970,415*

10.    

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

  ☐

11.    

  Percent of Class Represented by Amount in Row (9)

 

  16.1%

12.    

  Type of Reporting Person (See Instructions)

 

  PN

 

*

Consists of 4,019,574 shares of Common Stock and 1,196,908 shares of Common Stock issuable upon exercise of warrants held by MPM BioVentures IV-QP, L.P. (“BV IV QP”), 154,861 shares of Common Stock and 46,112 shares of Common Stock issuable upon exercise of warrants held by MPM BioVentures IV GmbH & Co. Beteiligungs KG (“BV KG”) and 1,447,562 shares of Common Stock and 105,398 shares of Common Stock issuable upon exercise of warrants held by MPM Bio IV NVS Strategic Fund, L.P. (“BV SF”). The warrants listed above are exercisable within 60 days of the date of this filing. The Reporting Person is the direct general partner of BV IV QP, BV KG and BV SF.

 

Page 6 of 15


CUSIP No. 16706W 10 2

 

  1.    

  Name of Reporting Persons

 

  MPM BioVentures IV LLC

  2.    

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☐        (b)  ☒

 

  3.    

  SEC USE ONLY

 

  4.    

  Citizenship or Place of Organization

 

  Delaware

Number of

Shares

  Beneficially  

Owned by

Each

Reporting

Person

With:

    5.     

  Sole Voting Power

 

  0

  6.     

  Shared Voting Power

 

  6,790,415*

  7.     

  Sole Dispositive Power

 

  0

  8.     

  Shared Dispositive Power

 

  6,790,415*

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  6,790,415*

10.    

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

  ☐

11.    

  Percent of Class Represented by Amount in Row (9)

 

  16.1%

12.    

  Type of Reporting Person (See Instructions)

 

  OO

 

*

Consists of 4,019,574 shares of Common Stock and 1,196,908 shares of Common Stock issuable upon exercise of warrants held by BV IV QP, 154,861 shares of Common Stock and 46,112 shares of Common Stock issuable upon exercise of warrants held by BV KG and 1,447,562 shares of Common Stock and 105,398 shares of Common Stock issuable upon exercise of warrants held by BV SF. The warrants listed above are exercisable within 60 days of the date of this filing. The Reporting Person is the indirect general partner of BV IV QP, BV KG and BV SF.

 

Page 7 of 15


CUSIP No. 16706W 10 2

 

  1.    

  Name of Reporting Persons

 

  Luke Evnin

  2.    

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☐        (b)  ☒

 

  3.    

  SEC USE ONLY

 

  4.    

  Citizenship or Place of Organization

 

  United States

Number of

Shares

  Beneficially  

Owned by

Each

Reporting

Person

With:

    5.     

  Sole Voting Power

 

  0

  6.     

  Shared Voting Power

 

  7,118,747*

  7.     

  Sole Dispositive Power

 

  0

  8.     

  Shared Dispositive Power

 

  7,118,747*

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  7,118,747*

10.    

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

  ☐

11.    

  Percent of Class Represented by Amount in Row (9)

 

  16.4%

12.    

  Type of Reporting Person (See Instructions)

 

  IN

 

*

Consists of 4,019,574 shares of Common Stock and 1,196,908 shares of Common Stock issuable upon exercise of warrants held by BV IV QP, 154,861 shares of Common Stock and 46,112 shares of Common Stock issuable upon exercise of warrants held by BV KG, 1,447,562 shares of Common Stock and 105,398 shares of Common Stock issuable upon exercise of warrants held by BV SF and 114,299 shares of Common Stock and 34,033 shares of Common Stock issuable upon exercise of warrants held by MPM Asset Management Investors BV4 LLC (“AM BV4”). MPM BioVentures IV GP LLC (“MPM IV GP”) and MPM BioVentures IV LLC (“MPM IV LLC”) are the direct and indirect general partners of BV IV QP, BV KG and BV SF. The Reporting Person is a member of MPM IV LLC.

 

Page 8 of 15


CUSIP No. 16706W 10 2

 

  1.    

  Name of Reporting Persons

 

  Ansbert Gadicke

  2.    

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☐        (b)  ☒

 

  3.    

  SEC USE ONLY

 

  4.    

  Citizenship or Place of Organization

 

  United States

Number of

Shares

  Beneficially  

Owned by

Each

Reporting

Person

With:

    5.     

  Sole Voting Power

 

  0

  6.     

  Shared Voting Power

 

  7,118,747*

  7.     

  Sole Dispositive Power

 

  0

  8.     

  Shared Dispositive Power

 

  7,118,747*

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  7,118,747*

10.    

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

  ☐

11.    

  Percent of Class Represented by Amount in Row (9)

 

  16.4%

12.    

  Type of Reporting Person (See Instructions)

 

  IN

 

*

Consists of 4,019,574 shares of Common Stock and 1,196,908 shares of Common Stock issuable upon exercise of warrants held by BV IV QP, 154,861 shares of Common Stock and 46,112 shares of Common Stock issuable upon exercise of warrants held by BV KG, 1,447,562 shares of Common Stock and 105,398 shares of Common Stock issuable upon exercise of warrants held by BV SF and 114,299 shares of Common Stock and 34,033 shares of Common Stock issuable upon exercise of warrants held by AM BV4. MPM IV GP and MPM IV LLC are the direct and indirect general partners of BV IV QP, BV KG and BV SF. The Reporting Person is a member of MPM IV LLC.

 

Page 9 of 15


CUSIP No. 16706W 10 2

 

  1.    

  Name of Reporting Persons

 

  Todd Foley

  2.    

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☐        (b)  ☒

 

  3.    

  SEC USE ONLY

 

  4.    

  Citizenship or Place of Organization

 

  United States

Number of

Shares

  Beneficially  

Owned by

Each

Reporting

Person

With:

    5.     

  Sole Voting Power

 

  36,000*

  6.     

  Shared Voting Power

 

  7,118,747**

  7.     

  Sole Dispositive Power

 

  36,000*

  8.     

  Shared Dispositive Power

 

  7,118,747**

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  7,154,747* **

10.    

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

  ☐

11.    

  Percent of Class Represented by Amount in Row (9)

 

  16.5%

12.    

  Type of Reporting Person (See Instructions)

 

  IN

 

*

Includes 36,000 shares of Common Stock issuable pursuant to options which are exercisable within 60 days of December 31, 2019.

**

Consists of 4,019,574 shares of Common Stock and 1,196,908 shares of Common Stock issuable upon exercise of warrants held by BV IV QP, 154,861 shares of Common Stock and 46,112 shares of Common Stock issuable upon exercise of warrants held by BV KG, 1,447,562 shares of Common Stock and 105,398 shares of Common Stock issuable upon exercise of warrants held by BV SF and 114,299 shares of Common Stock and 34,033 shares of Common Stock issuable upon exercise of warrants held by AM BV4. MPM IV GP and MPM IV LLC are the direct and indirect general partners of BV IV QP, BV KG and BV SF. The Reporting Person is a member of MPM IV LLC.

 

Page 10 of 15


 

Item 1.      
   (a)    Name of Issuer
     

Chiasma, Inc.

   (b)    Address of Issuer’s Principal Executive Offices
     

460 Totten Pond Road, Suite 530

     

Waltham MA 02451

Item 2.      
   (a)    Name of Person Filing
     

MPM BioVentures IV-QP, L.P.

     

MPM BioVentures IV GmbH & Co. Beteiligungs KG

     

MPM Asset Management Investors BV4 LLC

     

MPM Bio IV NVS Strategic Fund, L.P.

     

MPM BioVentures IV GP LLC

     

MPM BioVentures IV LLC

     

Luke Evnin

     

Ansbert Gadicke

     

Todd Foley

   (b)    Address of Principal Business Office or, if none, Residence
     

c/o MPM Capital LLC

     

450 Kendall Street

     

Cambridge, MA 02142

   (c)    Citizenship
     

All entities were organized in Delaware except MPM BioVentures IV GmbH & Co. Beteiligungs KG, which was organized in Germany and MPM Bio IV NVS Strategic Fund, L.P., which was organized in Bermuda. The individuals are all United States citizens.

   (d)    Title of Class of Securities
     

Common Stock

   (e)    CUSIP Number
     

16706W 10 2

 

Item 3.

If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable

 

Page 11 of 15


 

Item 4.

Ownership

 

MPM Entity

   Shares
Held
Directly
     Shares
Issuable
Upon
Exercise of
Warrants
Held
Directly
     Sole
Voting
Power
     Shared
Voting
Power
     Sole
Dispositive
Power
     Shared
Dispositive
Power
     Beneficial
Ownership
     Percentage
of Class
 

BV IV QP

     4,019,574        1,196,908        5,216,482        0        5,216,482        0        5,216,482        12.1

BV KG

     154,861        46,112        200,973        0        200,973        0        200,973        0.5

BV SF

     1,447,562        105,398        1,552,960        0        1,552,960        0        1,552,960        3.7

AM BV4

     114,299        34,033        148,332        0        148,332        0        148,332        0.4

BV IV GP(1)

     0        0        0        6,970,415        0        6,970,415        6,970,415        16.1

BV IV LLC(2)

     0        0        0        6,970,415        0        6,970,415        6,970,415        16.1

Luke Evnin(3)

     0        0        0        7,118,747        0        7,118,747        7,118,747        16.4

Ansbert Gadicke(3)

     0        0        0        7,118,747        0        7,118,747        7,118,747        16.4

Todd Foley(3)(4)

     36,000        0        36,000        7,118,747        0        7,118,747        7,154,747        16.5

 

(1)

Consists of 4,019,574 shares of Common Stock and 1,196,908 shares of Common Stock issuable upon exercise of warrants held by BV IV QP, 154,861 shares of Common Stock and 46,112 shares of Common Stock issuable upon exercise of warrants held by BV KG and 1,447,562 shares of Common Stock and 105,398 shares of Common Stock issuable upon exercise of warrants held by BV SF. The warrants listed above are exercisable within 60 days of the date of this filing. The Reporting Person is the direct general partner of BV IV QP, BV KG and BV SF.

(2)

Consists of 4,019,574 shares of Common Stock and 1,196,908 shares of Common Stock issuable upon exercise of warrants held by BV IV QP, 154,861 shares of Common Stock and 46,112 shares of Common Stock issuable upon exercise of warrants held by BV KG and 1,447,562 shares of Common Stock and 105,398 shares of Common Stock issuable upon exercise of warrants held by BV SF. The warrants listed above are exercisable within 60 days of the date of this filing. The Reporting Person is the indirect general partner of BV IV QP, BV KG and BV SF.

(3)

Consists of 4,019,574 shares of Common Stock and 1,196,908 shares of Common Stock issuable upon exercise of warrants held by BV IV QP, 154,861 shares of Common Stock and 46,112 shares of Common Stock issuable upon exercise of warrants held by BV KG, 1,447,562 shares of Common Stock and 105,398 shares of Common Stock issuable upon exercise of warrants held by BV SF and 114,299 shares of Common Stock and 34,033 shares of Common Stock issuable upon exercise of warrants held by AM BV4. MPM IV GP and MPM IV LLC are the direct and indirect general partners of BV IV QP, BV KG and BV SF. The Reporting Person is a member of MPM IV LLC.

(4)

Includes 36,000 shares of Common Stock issuable pursuant to options which are exercisable within 60 days of December 31, 2019.

 

Item 5.

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  ☐.

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

Not Applicable

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

Not Applicable

 

Page 12 of 15


 

Item 8.

Identification and Classification of Members of the Group

Not Applicable

 

Item 9.

Notice of Dissolution of a Group

Not Applicable

 

Item 10.

Certification

Not Applicable

 

Page 13 of 15


 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 4, 2020

 

MPM BIOVENTURES IV-QP, L.P.   MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG
By:   MPM BioVentures IV GP LLC,   By:   MPM BioVentures IV GP LLC,
  its General Partner     in its capacity as the Managing Limited Partner
By:   MPM BioVentures IV LLC,   By:   MPM BioVentures IV LLC,
  its Managing Member     its Managing Member
By:  

/s/ Luke Evnin

  By:  

/s/ Luke Evnin

  Name: Luke Evnin     Name: Luke Evnin
  Title: Member     Title: Member
MPM ASSET MANAGEMENT INVESTORS BV4 LLC   MPM BIO IV NVS STRATEGIC FUND, L.P.
    By:   MPM BioVentures IV GP LLC,
By:  

/s/ Howard Rubin

    its General Partner
  Name: Howard Rubin    
  Title: Authorized Signatory   By:   MPM BioVentures IV LLC,
      its Managing Member
    By:  

/s/ Luke Evnin

      Name: Luke Evnin
      Title: Member
MPM BIOVENTURES IV GP LLC   MPM BIOVENTURES IV LLC
By:   MPM BioVentures IV LLC,   By:  

/s/ Luke Evnin

  its Managing Member   Name: Luke Evnin
    Title:   Member
By:  

/s/ Luke Evnin

   
Name:   Luke Evnin    
Title:   Member    
By:  

/s/ Luke Evnin

  By:  

/s/ Ansbert Gadicke

  Name: Luke Evnin     Name: Ansbert Gadicke
By:  

/s/ Todd Foley

   
 

Name: Todd Foley

   

EXHIBITS

 

A:

Joint Filing Agreement

 

Page 14 of 15

EX-99.A

EXHIBIT A

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of Chiasma, Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.

In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 4th day of February, 2020.

 

MPM BIOVENTURES IV-QP, L.P.   MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG
By:   MPM BioVentures IV GP LLC,   By:   MPM BioVentures IV GP LLC,
  its General Partner     in its capacity as the Managing Limited Partner
By:   MPM BioVentures IV LLC,   By:   MPM BioVentures IV LLC,
  its Managing Member     its Managing Member
By:  

/s/ Luke Evnin

  By:  

/s/ Luke Evnin

  Name: Luke Evnin     Name: Luke Evnin
  Title: Member     Title: Member
MPM ASSET MANAGEMENT INVESTORS BV4 LLC   MPM BIO IV NVS STRATEGIC FUND, L.P.
    By:   MPM BioVentures IV GP LLC,
By:  

/s/ Howard Rubin

    its General Partner
  Name: Howard Rubin    
  Title: Authorized Signatory   By:   MPM BioVentures IV LLC,
      its Managing Member
    By:  

/s/ Luke Evnin

      Name: Luke Evnin
      Title: Member
MPM BIOVENTURES IV GP LLC   MPM BIOVENTURES IV LLC
By:   MPM BioVentures IV LLC,   By:  

/s/ Luke Evnin

  its Managing Member   Name: Luke Evnin
    Title:   Member
By:  

/s/ Luke Evnin

   
Name:   Luke Evnin    
Title:   Member    
By:  

/s/ Luke Evnin

  By:  

/s/ Ansbert Gadicke

  Name: Luke Evnin     Name: Ansbert Gadicke
By:  

/s/ Todd Foley

   
 

Name: Todd Foley